These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 9581575)

  • 1. Mutagenesis of Glu403 to Cys in rabbit neutral endopeptidase-24.11 (neprilysin) creates a disulphide-linked homodimer: analogy with endothelin-converting enzyme.
    Hoang MV; Sansom CE; Turner AJ
    Biochem J; 1997 Nov; 327 ( Pt 3)(Pt 3):925-9. PubMed ID: 9581575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rat endothelin-converting enzyme-1 forms a dimer through Cys412 with a similar catalytic mechanism and a distinct substrate binding mechanism compared with neutral endopeptidase-24.11.
    Shimada K; Takahashi M; Turner AJ; Tanzawa K
    Biochem J; 1996 May; 315 ( Pt 3)(Pt 3):863-7. PubMed ID: 8645169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential structure-activity relationships of phosphoramidon analogues for inhibition of three metalloproteases: endothelin-converting enzyme, neutral endopeptidase, and angiotensin-converting enzyme.
    Kukkola PJ; Savage P; Sakane Y; Berry JC; Bilci NA; Ghai RD; Jeng AY
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S65-8. PubMed ID: 8587470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular pharmacology of endothelin converting enzymes.
    Turner AJ; Murphy LJ
    Biochem Pharmacol; 1996 Jan; 51(2):91-102. PubMed ID: 8615890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping the active site of endothelin-converting enzyme-1 through subsite specificity and mutagenesis studies: a comparison with neprilysin.
    Johnson GD; Swenson HR; Ramage R; Ahn K
    Arch Biochem Biophys; 2002 Feb; 398(2):240-8. PubMed ID: 11831855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rat big endothelin-1-induced bronchoconstriction and vasoconstriction in the isolated perfused rat lung: role of endothelin converting enzyme and neutral endopeptidase 24.11.
    Held HD; Raschak M; Uhlig S
    Naunyn Schmiedebergs Arch Pharmacol; 1997 May; 355(5):619-24. PubMed ID: 9151301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A three-dimensional model of endothelin-converting enzyme (ECE) based on the X-ray structure of neutral endopeptidase 24.11 (NEP).
    Bur D; Dale GE; Oefner C
    Protein Eng; 2001 May; 14(5):337-41. PubMed ID: 11438756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular cloning and biochemical characterization of a new mouse testis soluble-zinc-metallopeptidase of the neprilysin family.
    Ghaddar G; Ruchon AF; Carpentier M; Marcinkiewicz M; Seidah NG; Crine P; Desgroseillers L; Boileau G
    Biochem J; 2000 Apr; 347(Pt 2):419-29. PubMed ID: 10749671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The N-terminal segment of endothelin-converting enzyme (ECE)-1b contains a di-leucine motif that can redirect neprilysin to an intracellular compartment in Madin-Darby canine kidney (MDCK) cells.
    Cailler F; Zappulla JP; Boileau G; Crine P
    Biochem J; 1999 Jul; 341 ( Pt 1)(Pt 1):119-26. PubMed ID: 10377252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of neutral endopeptidase-24.11 (neprilysin) and endothelin-converting enzyme in human prostate cancer cell lines.
    Usmani BA; Harden B; Maitland NJ; Turner AJ
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():314S-317S. PubMed ID: 12193112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular modelling and site-directed mutagenesis of the active site of endothelin-converting enzyme.
    Sansom CE; Hoang MV; Turner AJ
    Protein Eng; 1998 Dec; 11(12):1235-41. PubMed ID: 9930673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble human endothelin-converting enzyme-1: expression, purification, and demonstration of pronounced pH sensitivity.
    Ahn K; Herman SB; Fahnoe DC
    Arch Biochem Biophys; 1998 Nov; 359(2):258-68. PubMed ID: 9808768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of phosphoramidon-sensitive metalloproteinases with endothelin-converting enzyme activity in porcine lung membrane.
    Sawamura T; Shinmi O; Kishi N; Sugita Y; Yanagisawa M; Goto K; Masaki T; Kimura S
    Biochim Biophys Acta; 1993 Feb; 1161(2-3):295-302. PubMed ID: 8431480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triple ACE-ECE-NEP inhibition in heart failure: a comparison with ACE and dual ECE-NEP inhibition.
    Mellin V; Jeng AY; Monteil C; Renet S; Henry JP; Thuillez C; Mulder P
    J Cardiovasc Pharmacol; 2005 Sep; 46(3):390-7. PubMed ID: 16116347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelin-converting enzyme-2 is a membrane-bound, phosphoramidon-sensitive metalloprotease with acidic pH optimum.
    Emoto N; Yanagisawa M
    J Biol Chem; 1995 Jun; 270(25):15262-8. PubMed ID: 7797512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of functionally active endothelin-converting enzyme by chronic neutral endopeptidase inhibition in experimental atherosclerosis.
    Grantham JA; Schirger JA; Wennberg PW; Sandberg S; Heublein DM; Subkowski T; Burnett JC
    Circulation; 2000 Apr; 101(16):1976-81. PubMed ID: 10779465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrolysis of peptide hormones by endothelin-converting enzyme-1. A comparison with neprilysin.
    Johnson GD; Stevenson T; Ahn K
    J Biol Chem; 1999 Feb; 274(7):4053-8. PubMed ID: 9933597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in the activity of amyloid-degrading metallopeptidases leads to disruption of memory in rats].
    Dubrovskaia NM; Nalivaeva NN; Plesneva SA; Feponova AA; Turner AJ; Zhuravin IA
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2009; 59(5):630-8. PubMed ID: 19947540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward an optimal joint recognition of the S1' subsites of endothelin converting enzyme-1 (ECE-1), angiotensin converting enzyme (ACE), and neutral endopeptidase (NEP).
    Inguimbert N; Coric P; Poras H; Meudal H; Teffot F; Fournié-Zaluski MC; Roques BP
    J Med Chem; 2002 Mar; 45(7):1477-86. PubMed ID: 11906289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that Asn542 of neprilysin (EC 3.4.24.11) is involved in binding of the P2' residue of substrates and inhibitors.
    Dion N; Le Moual H; Fournié-Zaluski MC; Roques BP; Crine P; Boileau G
    Biochem J; 1995 Oct; 311 ( Pt 2)(Pt 2):623-7. PubMed ID: 7487905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.